{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T14:46:20Z","timestamp":1785422780970,"version":"3.56.0"},"reference-count":20,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T00:00:00Z","timestamp":1667433600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Iron deficiency anemia (IDA) is a public health problem worldwide. Shengxuening Tablet (SXN) has been used for the treatment of various types of anemia, attaining high efficacy.<\/jats:p><jats:p><jats:bold>Objective:<\/jats:bold> To evaluate the safety of SXN as well as its preventive and therapeutic efficacy against IDA across different population groups.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> PubMed, Embase, Web of Science, the Cochrane Library, the China Knowledge Network, the China Biomedical Literature Database, the Wanfang Data Knowledge Service Platform, and the China Science and Technology Journal Database was searched for relevant clinical trials through June 2022 and a systematic review and meta-analysis of the identified studies was undertaken.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> A total of 39 trials involving 4,562 cases were included in the meta-analysis. The total efficiency of SXN was superior than the control group in improving red blood cell (RBC) count [SMD = 1.31, 95% CI (0.7, 1.91), <jats:italic>p<\/jats:italic> &amp;lt; 0.0001], hemoglobin (Hb) [SMD = 1.11, 95% CI (0.75, 1.46), <jats:italic>p<\/jats:italic> &amp;lt; 0.00001], mean corpuscular volume (MCV) [SMD = 0.5, 95% CI (0.33, 0.68), <jats:italic>p<\/jats:italic> &amp;lt; 0.00001], total serum iron (SI) levels [SMD = 1.87, 95% CI (1.3, 2.44), <jats:italic>p<\/jats:italic> &amp;lt; 0.00001], and transferrin saturation (TSAT) levels [SMD = 2.07, 95% CI (1.86, 2.27), <jats:italic>p<\/jats:italic> &amp;lt; 0.00001]. Besides, the total effects of SXN to improve mean corpuscular hemoglobin (MCH) [SMD = 0.12, 95% CI (\u22120.16, 0.4), <jats:italic>p<\/jats:italic> = 0.41], mean corpuscular hemoglobin concentration (MCHC) [SMD = 0.03, 95% CI (\u22120.18, 0.24), <jats:italic>p<\/jats:italic> = 0.77], hematocrit (HCT) [SMD = 0.65, 95% CI (\u22120.25, 1.55), <jats:italic>p<\/jats:italic> = 0.16], and serum ferritin (SF) levels [SMD = 0.59, 95% CI (\u22120.67, 1.85), <jats:italic>p<\/jats:italic> = 0.36] and reduce the total iron binding capacity (TIBC) [SMD = 0.34, 95% CI (\u22120.07, 0.74), <jats:italic>p<\/jats:italic> = 0.1] was comparable to that of iron supplementation. SXN significantly raised the total effective rates of IDA [risk ratio (RR) = 1.06, 95% CI (1.02, 1.09), <jats:italic>p<\/jats:italic> = 0.0005] and was associated with fewer adverse events [RR = 0.24, 95% CI (0.18, 0.31), <jats:italic>p<\/jats:italic> &amp;lt; 0.00001], fewer adverse pregnancy outcomes [RR = 0.34, 95% CI (0.2, 0.57), <jats:italic>p<\/jats:italic> &amp;lt; 0.0001], and lower anemia recurrence rates during pregnancy [RR = 0.29, 95% CI (0.1, 0.84), <jats:italic>p<\/jats:italic> = 0.02]. Regarding prevention, the effects of SXN to maintain the RBC count, Hb level and other IDA-related parameters were comparable to that of control group and SXN reduced the risk of IDA incidence during pregnancy.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> SXN demonstrated promising efficacy in the treatment and prevention of IDA and outperformed routine iron formulations in terms of safety, thus rendering SXN a reliable treatment option for IDA.<\/jats:p><jats:p><jats:bold>Systematic Review Registration:<\/jats:bold><jats:ext-link>https:\/\/www.crd.york.ac.uk\/prospero\/<\/jats:ext-link>, identifier: CRD42022353247.<\/jats:p>","DOI":"10.3389\/fphar.2022.1029641","type":"journal-article","created":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T13:19:43Z","timestamp":1667481583000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["The efficiency and safety of Shengxuening tablet on treating and preventing iron deficiency anemia: A systematic review and meta-analysis"],"prefix":"10.3389","volume":"13","author":[{"given":"Yanyu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dehao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jicong","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingjing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"107","DOI":"10.13457\/j.cnki.jncm.2014.09.049","article-title":"Application research of shengxuening tablets combined with compound ferrous sulfate and folic acid tablets for iron deficiency anemia in pregnancy period","volume":"46","author":"Chen","year":"2014","journal-title":"J. New Chin. Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.6039\/j.issn.1001-0408.2018.12.28","article-title":"Therapeutic efficacy of Shengxuening Tablets in the treatment of iron- deficiency anemia during pregnancy: A Meta-analysis","volume":"12","author":"Chen","year":"2018","journal-title":"Chin. Pharm."},{"key":"B3","doi-asserted-by":"publisher","first-page":"e2100139","DOI":"10.1002\/cbdv.202100139","article-title":"Shengxuening extracted from silkworm excrement mitigates myelosuppression via SCF-mediated JAK2\/STAT3 signaling","volume":"18","author":"Ding","year":"2021","journal-title":"Chem. Biodivers."},{"key":"B4","doi-asserted-by":"publisher","first-page":"8796234","DOI":"10.1155\/2019\/8796234","article-title":"Efficacy of SXN in the treatment of iron deficiency anemia: A phase IV clinical trial","volume":"2019","author":"Ding","year":"2019","journal-title":"Evid. Based. Complement. Altern. Med."},{"key":"B5","first-page":"1052","article-title":"Effect of Shengxuening tablet combined with Ferrous Lactate on hematological indexes and iron metabolism in patients with iron deficiency anemia during pregnancy","volume":"32","author":"Fei","year":"2021","journal-title":"Mod. Diagn Treat."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.3969\/j.issn.1001-1528.2016.06.001","article-title":"Effect of Shengxuenign Tablets on mice with cyclophosphamide-induced anemia and its mechanism","volume":"38","author":"Huang","year":"2016","journal-title":"Chin. Tradit. Pat. Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e1476","DOI":"10.1016\/s2214-109x(19)30414-0","article-title":"Iron-deficiency anaemia in pregnancy: The role of hepcidin","volume":"7","author":"Lewkowitz","year":"2019","journal-title":"Lancet. Glob. Health"},{"key":"B8","doi-asserted-by":"publisher","first-page":"334","DOI":"10.14035\/j.cnki.hljyy.2020.02.043","article-title":"Effect of Shengxuening tablet combined with Polysaccharide Iron Complex Capsule on pregnancy outcome of pregnant IDA patients","volume":"33","author":"Liu","year":"2020","journal-title":"Heilongjiang Med. J."},{"key":"B9","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/s0140-6736(15)60865-0","article-title":"Iron deficiency anaemia","volume":"387","author":"Lopez","year":"2016","journal-title":"Lancet"},{"key":"B10","doi-asserted-by":"publisher","first-page":"113448","DOI":"10.1016\/j.jep.2020.113448","article-title":"Possible mechanisms by which silkworm faeces extract ameliorates adenine-induced renal anaemia in rats","volume":"266","author":"Mei","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"3502","DOI":"10.4268\/cjcmm20132019","article-title":"Study on fingerprint of shengxuening tablets","volume":"38","author":"Nie","year":"2013","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2894","DOI":"10.13241\/j.cnki.pmb.2018.15.019","article-title":"Curative effect of Shengxuening Tablets combined with Ferrous Succinate Tablets on patients with iron deficiency anemia during pregnancy","volume":"18","author":"Ruan","year":"2018","journal-title":"Prog. Mod. Biomed."},{"key":"B13","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s11655-007-0033-9","article-title":"Treatment of 37 patients with refractory idiopathic thrombocytopenic purpura by shengxueling","volume":"13","author":"Shao","year":"2007","journal-title":"Chin. J. Integr. Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1136\/gutjnl-2021-325210","article-title":"British Society of Gastroenterology guidelines for the management of iron deficiency anaemia in adults","volume":"70","author":"Snook","year":"2021","journal-title":"Gut"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e189","DOI":"10.1016\/s2214-109x(20)30448-4","article-title":"Efficacy and safety of intravenous ferric carboxymaltose compared with oral iron for the treatment of iron deficiency anaemia in women after childbirth in Tanzania: A parallel-group, open-label, randomised controlled phase 3 trial","volume":"9","author":"Vanobberghen","year":"2021","journal-title":"Lancet. Glob. Health"},{"key":"B16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3969\/j.issn.1673-548X.2005.09.003","article-title":"Shengxuening Tablet, a Class II new Chinese medicine, from silkworm excrement","volume":"34","author":"Wei","year":"2005","journal-title":"Bull. Med. Res."},{"key":"B17","first-page":"5","article-title":"Clinical study on treatment of iron deficiency anemia with Shengxuening","volume":"26","author":"Wei","year":"1997","journal-title":"Bull. Med. Res."},{"key":"B20","first-page":"33","article-title":"Effect of Shengxuening combined with ferrous succinate on iron deficiency anemia during pregnancy","author":"Yang","year":"2021","journal-title":"Zhongguo Xiangcun Yiyao"},{"key":"B18","doi-asserted-by":"publisher","first-page":"245","DOI":"10.2478\/jtim-2020-0037","article-title":"Shengxuening versus oral iron supplementation for the treatment of renal anemia: A systematic review","volume":"8","author":"Zeng","year":"2020","journal-title":"J. Transl. Int. Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/bf02857362","article-title":"Clinical observation on treatment of chronic aplastic anemia by Shengxuening and cyclosporin A","volume":"12","author":"Zhang","year":"2006","journal-title":"Chin. J. Integr. Med."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.1029641\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T13:19:56Z","timestamp":1667481596000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.1029641\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,3]]},"references-count":20,"alternative-id":["10.3389\/fphar.2022.1029641"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.1029641","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,3]]},"article-number":"1029641"}}